stockrow
Friday 6 November 2026
Export OPRX’s income statement to Excel — free account
OptimizeRx Corp.
OPRX Healthcare Health Information Services
OptimizeRx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $109.4 million, up 18.8% from fiscal 2024.
- Revenue
- −29.8%
- EPS
- −150.0%
- Free cash flow
- +89.9%
- Total debt
- −33.1%
Quarter to June 2026, against a year earlier
8.70
0.03
+0.35%
Follow OPRX
Alert me
OptimizeRx Corp. (OPRX) P/E ratio
As of 5 November 2026, OptimizeRx Corp. (OPRX) trades at a P/E ratio of 35.8×. Over the past ten years it has ranged from 0.0× (December 2025) to 25,457× (November 2018); the current reading is higher than 82% of that period. That is below the Health Information Services industry median of 42.0× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 45.4× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 2,736× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 530× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 23.8× | 36.62% |
| Mar 2026 | 17.4× | (61.58%) |
| Dec 2025 | 45.4× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 25,457×
Ten-year median
0.0×
Current reading's percentile
82
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SY So-Young International Inc. Sponsored ADR compare | n/m |
| DH Definitive Healthcare Corp. compare | n/m |
| LFMD LifeMD, Inc. compare | n/m |
| HCAT Health Catalyst, Inc. compare | n/m |
| AMWL American Well Corporation compare | n/m |
| CARL Carlsmed, Inc. compare | n/m |
| CTEV Claritev Corporation compare | n/m |
| SPOK Spok Holdings, Inc. compare | 12.9× |
| OPRX OptimizeRx Corp. | 35.8× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)